Article
FLT3 internal tandem duplication and FLT3-D835 mutation in 80 AML patients categorized into cytogenetic risk groups.
Postepy higieny i medycyny doswiadczalnej (Online) - 18 Oct 2010
Mały Ewa, Przyborsk Marta, Nowak Tomasz, Nowak Jerzy, Januszkiewicz Danuta
Abstract excerpt
BACKGROUND: Acute myeloid leukemia (AML) is a clonal disorder characterized by various genetic abnormalities and variable response to treatment. About 50% of patients with AML have no cytogenetic aberrations, presenting normal karyotype, and are categorized in the intermediate risk group. In this group detection of FLT3 mutations move a patient from the intermediate to the adverse risk group. MATERIAL/METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
